Adams Diversified Equity Fund’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $43.5M | Buy |
172,800
+43,400
| +34% | +$9.34M | 1.33% | 16 |
|
|
2026
Q1 | $28.1M | Sell |
129,400
-58,300
| -31% | -$12.9M | 0.99% | 24 |
|
|
2025
Q4 | $42.9M | Hold |
187,700
| – | – | 1.43% | 15 |
|
|
2025
Q3 | $43.5M | Hold |
187,700
| – | – | 1.46% | 14 |
|
|
2025
Q2 | $34.8M | Hold |
187,700
| – | – | 1.25% | 18 |
|
|
2025
Q1 | $39.3M | Sell |
187,700
-3,100
| -2% | -$603K | 1.57% | 12 |
|
|
2024
Q4 | $33.9M | Sell |
190,800
-8,200
| -4% | -$1.51M | 1.28% | 17 |
|
|
2024
Q3 | $39.3M | Sell |
199,000
-23,200
| -10% | -$4.33M | 1.44% | 11 |
|
|
2024
Q2 | $38.1M | Buy |
222,200
+42,200
| +23% | +$6.99M | 1.3% | 13 |
|
|
2024
Q1 | $32.8M | Buy |
+180,000
| New | +$31M | 1.16% | 20 |
|
|
2023
Q2 | – | Sell |
-179,776
| Closed | -$28.7M | – | 93 |
|
|
2023
Q1 | $28.7M | Buy |
179,776
+50,476
| +39% | +$7.72M | 1.29% | 18 |
|
|
2022
Q4 | $20.9M | Buy |
129,300
+45,500
| +54% | +$6.98M | 1% | 35 |
|
|
2022
Q3 | $11.2M | Sell |
83,800
-34,000
| -29% | -$4.88M | 0.56% | 73 |
|
|
2022
Q2 | $18M | Sell |
117,800
-98,800
| -46% | -$15.1M | 0.86% | 45 |
|
|
2022
Q1 | $35.1M | Sell |
216,600
-102,600
| -32% | -$14.9M | 1.4% | 15 |
|
|
2021
Q4 | $43.2M | Buy |
319,200
+111,200
| +53% | +$13.1M | 1.64% | 11 |
|
|
2021
Q3 | $22.4M | Sell |
208,000
-114,200
| -35% | -$13M | 0.89% | 36 |
|
|
2021
Q2 | $36.3M | Buy |
322,200
+81,300
| +34% | +$9.16M | 1.43% | 14 |
|
|
2021
Q1 | $26.1M | Hold |
240,900
| – | – | 1.11% | 25 |
|
|
2020
Q4 | $25.8M | Sell |
240,900
-40,200
| -14% | -$3.86M | 1.17% | 21 |
|
|
2020
Q3 | $24.6M | Buy |
281,100
+65,600
| +30% | +$6.18M | 1.2% | 20 |
|
|
2020
Q2 | $21.2M | Sell |
215,500
-107,200
| -33% | -$9.44M | 1.12% | 22 |
|
|
2020
Q1 | $24.6M | Hold |
322,700
| – | – | 1.56% | 12 |
|
|
2019
Q4 | $28.6M | Buy |
+322,700
| New | +$26.8M | 1.47% | 20 |
|
|
2018
Q3 | – | Sell |
-265,700
| Closed | -$24.6M | – | 212 |
|
|
2018
Q2 | $24.6M | Hold |
265,700
| – | – | 1.31% | 25 |
|
|
2018
Q1 | $25.1M | Sell |
265,700
-57,500
| -18% | -$6.32M | 1.38% | 24 |
|
|
2017
Q4 | $31.3M | Sell |
323,200
-56,800
| -15% | -$5.35M | 1.68% | 16 |
|
|
2017
Q3 | $33.8M | Hold |
380,000
| – | – | 1.83% | 10 |
|
|
2017
Q2 | $27.6M | Hold |
380,000
| – | – | 1.56% | 17 |
|
|
2017
Q1 | $24.8M | Hold |
380,000
| – | – | 1.42% | 18 |
|
|
2016
Q4 | $23.8M | Hold |
380,000
| – | – | 1.47% | 19 |
|
|
2016
Q3 | $23.5M | Hold |
380,000
| – | – | 1.58% | 19 |
|
|
2016
Q2 | $23.5M | Hold |
380,000
| – | – | 1.58% | 19 |
|
|
2016
Q1 | $21.7M | Hold |
380,000
| – | – | 1.51% | 23 |
|
|
2015
Q4 | $22.5M | Buy |
+380,000
| New | +$21.9M | 1.55% | 22 |
|
|
2015
Q2 | – | Sell |
-20,000
| Closed | -$1.17M | – | 84 |
|
|
2015
Q1 | $1.17M | Hold |
20,000
| – | – | 0.08% | 85 |
|
|
2014
Q4 | $1.31M | Sell |
20,000
-260,000
| -93% | -$16.4M | 0.09% | 85 |
|
|
2014
Q3 | $16.2M | Hold |
280,000
| – | – | 1.07% | 37 |
|
|
2014
Q2 | $15.8M | Hold |
280,000
| – | – | 1.06% | 39 |
|
|
2014
Q1 | $14.4M | Buy |
+280,000
| New | +$14.2M | 1.02% | 38 |
|
Other funds holding ABBV
Adams Diversified Equity Fund's ABBV Position: Q2 2026 in Review
Adams Diversified Equity Fund increased its AbbVie (ABBV) stake by 34% in Q2 2026, buying an estimated $9.34M and bringing the position to 172,800 shares worth $43.5M. The position accounts for 1.33% of the portfolio, ranked #16.
Adams Diversified Equity Fund first reported a position in ABBV in Q1 2014 and has held it in 40 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Adams Diversified Equity Fund held 172,800 shares of AbbVie worth $43.5M as of Q2 2026.
- Adams Diversified Equity Fund bought 43,400 AbbVie shares in Q2 2026, an estimated $9.34M.
- AbbVie made up 1.33% of Adams Diversified Equity Fund's portfolio in Q2 2026, its #16 holding.
- Adams Diversified Equity Fund first reported a position in AbbVie in Q1 2014 and has held it in 40 quarters since.
- 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Adams Diversified Equity Fund's 13F filing for Q2 2026, filed 22 Jul 2026.